Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review.
AMR
Antibiotic resistance
Awareness
Behaviour change
Health knowledge and attitudes
Public campaign
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
06 02 2024
06 02 2024
Historique:
received:
06
10
2023
accepted:
13
01
2024
medline:
8
2
2024
pubmed:
7
2
2024
entrez:
6
2
2024
Statut:
epublish
Résumé
Public health campaigns with a well-defined outcome behaviour have been shown to successfully alter behaviour. However, the complex nature of antimicrobial resistance (AMR) creates challenges when evaluating campaigns aimed at raising awareness and changing behaviour. To determine what campaigns have been conducted and which reported being effective at improving awareness of antimicrobial resistance and changing behaviour around antimicrobial use in members of the public. It also sought to determine the outcome measures studies have used to assess campaign effectiveness. A systematic search of Ovid MEDLINE and Embase, was conducted in October 2022 using a predefined search strategy. Studies which were published between 2010 and September 2022 that outlined a campaign or invention aimed at the public and focusing on AMR or antibiotic usage were eligible for inclusion and studies which solely targeted healthcare professionals (HCP) were excluded. Literature searches retrieved 6961 results. De-duplication and screening removed 6925 articles, five articles from grey literature and reference screening were included, giving a total of 41 studies and 30 unique interventions. There was a distribution of campaigns globally with the majority run in Europe (n = 15) with most campaigns were conducted nationally (n = 14). Campaigns tended to focus on adult members of the public (n = 14) or targeted resources towards both the public and HCPs (n = 13) and predominately assessed changes in knowledge of and/or attitudes towards AMR (n = 16). Campaigns where an improvement was seen in their primary outcome measure tended to use mass media to disseminate information, targeted messaging towards a specific infection, and including the use of HCP-patient interactions. This review provides some evidence that campaigns can significantly improve outcome measures relating to AMR and antibiotic usage. Despite a lack of homogeneity between studies some common themes emerged between campaigns reported as being effective. However, the frequent use of observational study designs makes it difficult to establish causation between the campaign and changes seen in the studies outcome measures. It is important that clear evaluation processes are embedded as part of the design process for future campaigns; a campaign evaluation framework for use by campaign developers may facilitate this.
Identifiants
pubmed: 38321479
doi: 10.1186/s12889-024-17766-w
pii: 10.1186/s12889-024-17766-w
pmc: PMC10848528
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
396Informations de copyright
© 2024. Crown.
Références
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Int J Clin Pharm. 2017 Feb;39(1):120-125
pubmed: 27905077
BMJ. 2013 Sep 12;347:f5391
pubmed: 24030722
Antimicrob Resist Infect Control. 2021 Feb 4;10(1):29
pubmed: 33541440
J Antimicrob Chemother. 2011 Dec;66(12):2872-9
pubmed: 21965428
Fam Pract. 2018 Jul 23;35(4):461-467
pubmed: 29300965
J Health Psychol. 2019 Apr;24(5):623-627
pubmed: 28810368
Saudi Pharm J. 2016 Sep;24(5):611-615
pubmed: 27752235
Eur J Health Econ. 2013 Aug;14(4):587-99
pubmed: 22706960
J Educ Health Promot. 2021 Jan 28;10:3
pubmed: 33688512
Drug Alcohol Depend. 2014 Feb 1;135:52-8
pubmed: 24322004
J Antimicrob Chemother. 2011 Jun;66 Suppl 5:v3-12
pubmed: 21680584
J Antimicrob Chemother. 2011 Jun;66 Suppl 5:v55-7
pubmed: 21680589
PLoS One. 2017 Feb 17;12(2):e0172146
pubmed: 28212400
Cancer Control. 2022 Jan-Dec;29:10732748221079480
pubmed: 35403444
Perspect Public Health. 2020 Nov;140(6):338-350
pubmed: 32515278
Am J Infect Control. 2020 Apr;48(4):433-442
pubmed: 31444097
Aten Primaria. 2014 Aug-Sep;46(7):367-75
pubmed: 24581680
Health Promot Pract. 2012 Jul;13(4):481-8
pubmed: 21441207
Saudi J Biol Sci. 2017 May;24(4):808-812
pubmed: 28490950
Health Res Policy Syst. 2016 Nov 25;14(1):83
pubmed: 27884208
Eur J Cardiovasc Nurs. 2021 Jun 29;20(5):515-519
pubmed: 34007994
Health Commun. 2019 Feb;34(2):248-258
pubmed: 29206493
BMC Public Health. 2017 Jul 11;18(1):5
pubmed: 28693462
Expert Rev Anti Infect Ther. 2015 Feb;13(2):279-89
pubmed: 25495147
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4106-18
pubmed: 27139474
J Public Health (Oxf). 2017 Jun 1;39(2):e40-e47
pubmed: 27451416
BMC Public Health. 2014 Aug 22;14:866
pubmed: 25149626
Front Vet Sci. 2019 Nov 22;6:421
pubmed: 31824973
Arch Dis Child. 2011 Nov;96(11):1033-7
pubmed: 21771764
Eur J Pediatr. 2011 Mar;170(3):359-64
pubmed: 20865279
Expert Rev Anti Infect Ther. 2020 Aug;18(8):697-699
pubmed: 32281427
ACP J Club. 1995 Nov-Dec;123(3):A12-3
pubmed: 7582737
Int J Environ Res Public Health. 2020 Apr 28;17(9):
pubmed: 32354155
BMC Public Health. 2019 May 10;19(Suppl 3):498
pubmed: 32326918
J Antimicrob Chemother. 2010 Jul;65(7):1526-33
pubmed: 20488985
Acad Pediatr. 2022 May-Jun;22(4):526-539
pubmed: 34906742
Antibiotics (Basel). 2019 Mar 09;8(1):
pubmed: 30857297
J Antimicrob Chemother. 2017 Apr 1;72(4):975-987
pubmed: 27999058
BJGP Open. 2020 Aug 25;4(3):
pubmed: 32665235
Scand J Infect Dis. 2012 Jul;44(7):495-501
pubmed: 22497317
JAC Antimicrob Resist. 2020 Mar 18;2(1):dlaa003
pubmed: 34222961
J Antimicrob Chemother. 2020 Jan 1;75(1):14-29
pubmed: 31834401
J Med Internet Res. 2015 Oct 15;17(10):e233
pubmed: 26471079
J Health Commun. 2018;23(1):109-116
pubmed: 29272208
Antimicrob Agents Chemother. 2014;58(1):71-7
pubmed: 24126584
BMC Infect Dis. 2014 Jan 09;14:13
pubmed: 24405683
Can J Public Health. 2010 Jul-Aug;101(4):304-8
pubmed: 21033536
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Open Forum Infect Dis. 2020 Nov 06;7(11):ofaa452
pubmed: 33204753
BMJ Open. 2016 Oct 24;6(10):e012244
pubmed: 27798010
Antimicrob Steward Healthc Epidemiol. 2021 Nov 02;1(1):e37
pubmed: 36168485
Public Underst Sci. 2019 May;28(4):486-503
pubmed: 30755136
Pol Merkur Lekarski. 2010 Nov;29(173):296-303
pubmed: 21268913
Eur J Public Health. 2018 Jun 1;28(3):437-439
pubmed: 29401283
BMC Public Health. 2016 May 12;16:393
pubmed: 27177032
Med Princ Pract. 2012;21(1):97
pubmed: 22025092
Can J Infect Dis Med Microbiol. 2011 Spring;22(1):19-24
pubmed: 22379484
PLoS Med. 2019 Jun 11;16(6):e1002819
pubmed: 31185011
J Glob Antimicrob Resist. 2014 Dec;2(4):334-337
pubmed: 27873698
J Health Psychol. 2019 Jan;24(1):113-124
pubmed: 28810435
Acta Clin Belg. 2021 Aug;76(4):280-288
pubmed: 32024450
BMJ Open. 2019 Oct 28;9(10):e030845
pubmed: 31662380
Int J Pharm Pract. 2017 Feb;25(1):93-96
pubmed: 27443787
J Antimicrob Chemother. 2011 Jun;66 Suppl 5:v51-3
pubmed: 21680588